Objective: The objective of the study was to review prescribing of psychoactive medications for older residents of the Tayside region of Scotland.

Methods: The analysis used community prescribing data in 1995 and 2010 for all older residents in Tayside. For each psychoactive drug class, the name of the most recently prescribed drug and the date prescribed were extracted. The relative risk (RR) and 95% confidence intervals (CI) for patients receiving psychoactive medication in 2010 were compared with those for patients in 1995. Psychoactive prescribing was analyzed by year, age, gender, and deprivation classification. The chi-squared test was used to calculate statistical significance.

Results: Total psychoactive prescribing in people over the age of 65 years has increased comparing 1995 with 2010. Antidepressant [RR = 2.5 (95% CI 2.41-2.59) p < 0.001] and opioid analgesia [RR = 1.21 (1.19-1.24) p < 0.001] prescriptions increased between 1995 and 2010. Hypnotics/anxiolytic [RR = 0.69 (0.66-0.71) p < 0.001] and antipsychotic [RR = 0.83 (0.77-0.88) p < 0.001] prescriptions decreased between 1995 and 2010. An increase in psychoactive prescribing is particularly marked in lower socioeconomic groups. Patients in the least affluent fifth of the population had RR = 1.25 (1.20-1.29) [p < 0.001] of being prescribed one to two psychoactive medications and RR = 1.81 (1.56-2.10) [p < 0.001] of being prescribed three or more psychoactive medications in 2010 compared with those in 1995. The RRs for the most affluent fifth were RR = 1.14 (1.1-1.19) [p < 0.001] and RR = 1.2 (1.01-1.42) [p < 0.001] for one to two, and three or more medications, respectively.

Conclusion: Psychoactive medication prescribing has increased comparing 1995 with 2010, with increases disproportionately affecting patients in lower socioeconomic groups. The availability of new psychoactive drugs, safety concerns, and economic factors may explain these increases.

Download full-text PDF

Source
http://dx.doi.org/10.1002/gps.4288DOI Listing

Publication Analysis

Top Keywords

psychoactive prescribing
12
older residents
8
residents tayside
8
1995 2010
8
psychoactive
6
prescribing older
4
older people--what
4
people--what difference
4
difference years
4
years make?
4

Similar Publications

As psilocybin awaits approval by the Food and Drug Administration (FDA), scholars debate whether psychedelic-assisted psychotherapy should be required when prescribing this medicine. Here, we report the case of a patient who underwent a psilocybin experience without psychedelic-assisted psychotherapy, resulting in inpatient psychiatric admission. This case underscores the importance of taking psilocybin in controlled clinical settings.

View Article and Find Full Text PDF

Medicinal Cannabis and the Intestinal Microbiome.

Pharmaceuticals (Basel)

December 2024

Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia.

Historically, the multiple uses of cannabis as a medicine, food, and for recreational purposes as a psychoactive drug span several centuries. The various components of the plant (i.e.

View Article and Find Full Text PDF

Patterns of Opioid and NSAID Use in Saudi Arabia from 2010 to 2020.

J Psychoactive Drugs

January 2025

Department of Pharmaceutical Care, King Fahad Medical City, Riyadh, Saudi Arabia.

The use of analgesics has increased globally over the last three decades. Prescription drug abuse has increased significantly, and opioids have been identified as causing further harm to the world. This study explored the utilization and expenditure associated with opioids and non-steroidal anti-inflammatory drugs (NSAIDs) from 2010 to 2020 in Saudi Arabia.

View Article and Find Full Text PDF
Article Synopsis
  • - Methylphenidate (MPH), often used to treat ADHD, is increasingly misused by individuals with co-occurring psychiatric and substance use disorders, raising concerns about dependence and adverse effects.
  • - A systematic review conducted in 2024 analyzed 12 studies, focusing on patterns of MPH misuse among patients with various psychiatric disorders, including conduct, mood, and anxiety disorders.
  • - The results showed a significant correlation between MPH misuse and individuals with psychiatric disorders, particularly those also suffering from Alcohol Use Disorder, highlighting the need for targeted interventions and monitoring.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!